The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (13 analysts) rates it buy, with a mean price target of $143.
Bank Of New York Mellon Corp BNY
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally.
read at $158.91
Bank Of New York Mellon Corp holds its Markup at $158.91.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 60 days |
| Price | $158.91 |
| Valuation | 18.54 trailing · 15.54 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.06 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 13.10% |
| Profit margin | 29.41% |
| Analyst consensus | Buy · 14 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its excluded industry: banks - diversified. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Excluded industry: Banks - Diversified Fail
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Banks Move Money but Fail Our Screen
Every pension payout or trade settlement that crosses continents runs through custody banks like BNY Mellon. The business shows steady 13% revenue growth, a 29% profit margin and 14% ROE, yet none of that matters once the ethical screen flags the entire diversified banks sector. We pass, full stop.
At 15.5 times forward earnings the shares sit close to our fair value with only a 4% margin of safety. Thirteen analysts call it a buy with a 175 median target, but our opportunity rating stays at none because the ethical exclusion overrides any valuation signal.
Bank earnings remain hostage to interest-rate swings, regulatory shifts and fee pressure that can erase apparently cheap multiples in a single cycle. The narrow moat offers little protection when the next policy change arrives. Analysis, not advice.
| Forward P/E | 15.5x fairly priced for its growth rate |
| Trailing P/E | 18.5x reasonably valued |
| Revenue growth | 13.1% steady growth |
| Profit margin | 29.4% healthy profit margins |
| Return on equity | 14.1% a solid return on shareholder capital |
| Beta | 1.06 moves a little more than the market |
| Market cap | $107.8B |
| Employees | 47,200 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on BNY
- › FNB Q2 Earnings Meet Estimates, Revenues Rise Y/Y to Record Levels Zacks · 15d ago
- › CBSH Stock Gains on Q2 Earnings Beat, Revenues & Costs Rise Y/Y Zacks · 15d ago
- › 2 Large-Cap Stocks to Target This Week and 1 We Question StockStory · 15d ago
- › Stop Worrying About AI and Focus on the Rest of the Market Barrons.com · 15d ago
- › Wealth Management Units Deliver Robust Results for Banks. Morgan Stanley Leads the Pack. Barrons.com · 16d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in BNY's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (13 analysts) rates it buy, with a mean price target of $143.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $132.49 | +6.1% | · | $1,061 | +6.1% |
| 2 months | $127.06 | +10.7% | $0.53 | $1,111 | +11.1% |
| 3 months | $116.66 | +20.5% | $0.53 | $1,210 | +21.0% |
| 6 months | $117.69 | +19.5% | $1.06 | $1,204 | +20.4% |
| 1 year | $88.34 | +59.2% | $2.12 | $1,616 | +61.6% |
| 2 years | $58.13 | +141.9% | $4.00 | $2,488 | +148.8% |
| 3 years | $41.08 | +242.2% | $5.68 | $3,561 | +256.1% |
| 5 years | $43.89 | +220.4% | $8.52 | $3,398 | +239.8% |
Historical returns from market close data. Past performance does not guarantee future results.